Dual AU and UK Medical Device Registration for AI Capability
Filed with ASX · · 2 pages · English
Melbourne, Victoria | Alcidion Group Limited (ASX:ALC) (‘Alcidion’ or the ‘Company’) advises that its Miya Precision Concept Detection capability has been registered as a Class I Software as a Medical Device (SaMD) on the Australian Register of Therapeutic Goods (ARTG #522634) and with the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA). This dual registration enables A
Earlier from Alcidion
- Q2 FY26 Quarterly Activities Report and Appendix 4C
- Alcidion Selected as Preferred EPR Supplier
- Alcidion expands contract with Leidos Australia
- Q1 FY26 Quarterly Activities Report and Appendix 4C
- 2025 Annual General Meeting Chair Address & Presentation
Later from Alcidion
- H1 FY26 Appendix 4D and Half Year Report
- H1 FY26 Results Presentation
- H1 FY26 Results Release
- Q3 FY26 Quarterly Activities Report and Appendix 4C
- Acquisition of the Kyra flow products from Telstra Health
Follow Alcidion into a list and get an email when it puts out news.
Follow Alcidion